Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Idogen

Idogen
2008 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
IDOGEN STOCK SYMBOL
$0.08 SHARE PRICE (As of Friday Closing)
Description

Idogen AB is a Swedish biotech company engaged in developing tolerogenic cell therapies to prevent biological drugs, transplanted or body cells or tissues from being attacked by the patient's immune system.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
SAT
Primary Office
  • Medicon Village
  • Scheelevagen 2
  • 223 81 Lund
  • Sweden

+46 046-275 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Idogen’s full profile, request a free trial.

Idogen Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.05 - $0.32 $3.89M $0.08 -$0.07 552K 48.5M

Idogen Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 1,965 773 5,484 17,548
Revenue 0 0 0 0
EBITDA (2,526) (3,062) (2,486) (1,471)
Net Income (3,144) (3,176) (2,495) (1,470)
Total Assets 3,939 7,974 5,397 2,269
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Idogen Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Idogen‘s full profile, request access.

Request full access to PitchBook

Idogen Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Idogen‘s full profile, request access.

Request full access to PitchBook

Idogen Executive Team (8)

Name Title Board
Seat
Contact
Info
Lars Hedbys Ph.D Co-Founder & Chief Executive Officer
Ingvar Karlsson Chief Financial Officer
Dennis Henriksen Ph.D Chief Technology Officer
Hanne Romedahl Chief Scientific Officer
Neil Thomas Ph.D Chief Business Officer

2 Former Executives

You’re viewing 5 of 8 executives. Get the full list »

Idogen Board Members (2)

Name Representing Role Since Contact
Info
0000 0000000 Self Co-Founder, Advisor & Board Member 000 0000
000000 Ø000 Ventac Partners Board Member 000 0000